Does financing biodiversity reduce biodiversity loss

Centre for Endowment Asset Management (CEAM)
Centre for Endowment Asset Management (CEAM)

Overview

This project, ‘Does Financing Biodiversity Reduce Biodiversity Loss? Evidence from EU Funding of Science and Innovation’, investigates whether biodiversity financing effectively reduces biodiversity loss and improves ecological outcomes.

It analyses 8,350 projects funded across Europe over 2 decades, categorising them as research-oriented or conservation-oriented. It highlights that conservation-focused projects show positive impacts on forest conservation, while research-oriented initiatives enhance biodiversity data coverage. However, the effectiveness varies due to ecological complexity, diminishing returns and external stressors.

The paper also explores the role of private capital, biotechnology innovation and genetic diversity in biodiversity financing, offering actionable insights for policymakers to optimise financing strategies.

An interview with Andre Poyser.

Author

Andre Poyser

Lecturer in Economics and Finance, Auckland University of Technology

Project aims

The research explores the effectiveness of biodiversity financing in reducing biodiversity loss and aims to address several critical questions. These include:

1

Assessing the impact of biodiversity financing

This is done by evaluating whether increased financing for biodiversity projects leads to measurable improvements in ecological outcomes, such as forest cover and species protection.

2

Differentiating project types into research-oriented (RO) and conservation-oriented (CO) projects

This is coupled with analysing the distinct impacts of each type. Research-oriented projects focus on improving biodiversity data collection and knowledge creation, while conservation-oriented projects aim at direct ecological interventions.

3

Understanding the role of private capital

This is achieved by investigating the viability and challenges of mobilising private capital for biodiversity finance, particularly for biotechnology projects, which have potential for commercialisation through innovations like genetic sequencing and patenting.

4

Exploring the research – conservation

This involves examining how scientific research feeds into conservation efforts and enhances their effectiveness. It highlights the complexity and indirect pathways linking research outcomes to tangible ecological improvements.

5

Evaluating policy and funding efficiency

This is completed by critically analysing the strategic alignment and efficiency of biodiversity financing across Europe, questioning whether the current allocation of resources effectively addresses biodiversity challenges.

Key insights

1

Funding biodiversity projects for conservation and research

Conservation-oriented projects, such as forest conservation efforts, are highly effective in reducing biodiversity loss, with measurable impacts on forest cover. Forest conservation responds faster than species-level dynamics, offering visible results. Research-oriented projects, on the other hand, expand biodiversity data coverage, providing essential information on species and ecosystems. However, excessive financing in research-focused projects shows diminishing returns, highlighting the need for balanced funding strategies.

2

Private sector contributions to biodiversity financing

Private investment in biotechnology offers significant potential despite challenges. Biotech innovations, such as advancements in DNA sequencing and patented technologies, show commercial promise in medicine, ecological genetics and pharmaceuticals. These breakthroughs could drive biodiversity conservation efforts further.

3

Commercialisation opportunities in biodiversity finance

Innovative financing tools, like the Rhino Bond for rhino conservation and the Svalbard Global Seed Vault for preserving genetic materials, showcase practical and scientific benefits of biodiversity financing. These projects combine conservation and commercial relevance.

4

Challenges in biodiversity finance

Biodiversity financing alone cannot fully address biodiversity loss. Factors like invasive species and land-use changes often overshadow the positive impacts of funding. Mobilising private capital remains difficult due to high costs and limited profitability of biodiversity projects, requiring clear incentives to attract private sector involvement.

5

Research limitations in biodiversity financing

Ecological system complexity makes it challenging to establish direct causal links between biodiversity financing and outcomes. This research identifies patterns and trends rather than definitive causation, offering insights into optimising biodiversity funding strategies.

Why this matters for investors

Emerging market opportunities

Biodiversity financing presents new investment avenues in sectors like biotechnology, ecological genetics and pharmaceuticals. Innovations such as DNA sequencing technologies and the Rhino Bond offer commercially viable solutions that align with conservation goals.

Financial returns and impact

Conservation-focused projects demonstrate tangible ecological outcomes, like improved forest cover, which can enhance carbon credit markets. Such measurable impacts provide opportunities for investors to align financial returns with environmental impact.

Risk mitigation

Biodiversity loss poses risks to global supply chains, especially in agriculture, pharmaceuticals and natural resources. Investing in biodiversity financing helps mitigate these risks by preserving ecosystems critical to long-term business viability.

Growing demand for green financing

Governments and institutions are incentivising private sector involvement in biodiversity conservation through mechanisms like green bonds and subsidies. Early investment positions investors to benefit from these favourable policies.

Innovative financing models

Tools like biodiversity bonds and genetic material vaults, such as the Svalbard Global Seed Vault, highlight scalable, innovative investment opportunities that combine scientific innovation with commercial potential.

Conclusion

This research underscores the nuanced effectiveness of biodiversity financing, highlighting conservation-oriented projects as most impactful for forest preservation while research-oriented projects excel in expanding biodiversity data. However, challenges such as ecological complexity and diminishing returns persist. The study also identifies promising biotechnology applications, offering pathways for private sector engagement. By leveraging actionable insights, policymakers and investors can optimise biodiversity financing strategies to address biodiversity loss effectively, balancing ecological outcomes with commercial innovation for a sustainable future.

Top